
- •Preface
- •List of contributers
- •History, epidemiology, prevention and education
- •A history of burn care
- •“Black sheep in surgical wards”
- •Toxaemia, plasmarrhea, or infection?
- •The Guinea Pig Club
- •Burns and sulfa drugs at Pearl Harbor
- •Burn center concept
- •Shock and resuscitation
- •Wound care and infection
- •Burn surgery
- •Inhalation injury and pulmonary care
- •Nutrition and the “Universal Trauma Model”
- •Rehabilitation
- •Conclusions
- •References
- •Epidemiology and prevention of burns throughout the world
- •Introduction
- •Epidemiology
- •The inequitable distribution of burns
- •Cost by age
- •Cost by mechanism
- •Limitations of data
- •Risk factors
- •Socioeconomic factors
- •Race and ethnicity
- •Age-related factors: children
- •Age-related factors: the elderly
- •Regional factors
- •Gender-related factors
- •Intent
- •Comorbidity
- •Agents
- •Non-electric domestic appliances
- •War, mass casualties, and terrorism
- •Interventions
- •Smoke detectors
- •Residential sprinklers
- •Hot water temperature regulation
- •Lamps and stoves
- •Fireworks legislation
- •Fire-safe cigarettes
- •Children’s sleepwear
- •Acid assaults
- •Burn care systems
- •Role of the World Health Organization
- •Conclusions and recommendations
- •Surveillance
- •Smoke alarms
- •Gender inequality
- •Community surveys
- •Acknowledgements
- •References
- •Prevention of burn injuries
- •Introduction
- •Burns prevalence and relevance
- •Burn injury risk factors
- •WHERE?
- •Burn prevention types
- •Burn prevention: The basics to design a plan
- •Flame burns
- •Prevention of scald burns
- •Conclusions
- •References
- •Burns associated with wars and disasters
- •Introduction
- •Wartime burns
- •Epidemiology of burns sustained during combat operations
- •Fluid resuscitation and initial burn care in theater
- •Evacuation of thermally-injured combat casualties
- •Care of host-nation burn patients
- •Disaster-related burns
- •Epidemiology
- •Treatment of disaster-related burns
- •The American Burn Association (ABA) disaster management plan
- •Summary
- •References
- •Education in burns
- •Introduction
- •Surgical education
- •Background
- •Simulation
- •Education in the internet era
- •Rotations as courses
- •Mentorship
- •Peer mentorship
- •Hierarchical mentorship
- •What is a mentor
- •Implementation
- •Interprofessional education
- •What is interprofessional education
- •Approaches to interprofessional education
- •References
- •European practice guidelines for burn care: Minimum level of burn care provision in Europe
- •Foreword
- •Background
- •Introduction
- •Burn injury and burn care in general
- •Conclusion
- •References
- •Pre-hospital and initial management of burns
- •Introduction
- •Modern care
- •Early management
- •At the accident
- •At a local hospital – stabilization prior to transport to the Burn Center
- •Transportation
- •References
- •Medical documentation of burn injuries
- •Introduction
- •Medical documentation of burn injuries
- •Contents of an up-to-date burns registry
- •Shortcomings in existing documentation systems designs
- •Burn depth
- •Burn depth as a dynamic process
- •Non-clinical methods to classify burn depth
- •Burn extent
- •Basic principles of determining the burn extent
- •Methods to determine burn extent
- •Computer aided three-dimensional documentation systems
- •Methods used by BurnCase 3D
- •Creating a comparable international database
- •Results
- •Conclusion
- •Financing and accomplishment
- •References
- •Pathophysiology of burn injury
- •Introduction
- •Local changes
- •Burn depth
- •Burn size
- •Systemic changes
- •Hypovolemia and rapid edema formation
- •Altered cellular membranes and cellular edema
- •Mediators of burn injury
- •Hemodynamic consequences of acute burns
- •Hypermetabolic response to burn injury
- •Glucose metabolism
- •Myocardial dysfunction
- •Effects on the renal system
- •Effects on the gastrointestinal system
- •Effects on the immune system
- •Summary and conclusion
- •References
- •Anesthesia for patients with acute burn injuries
- •Introduction
- •Preoperative evaluation
- •Monitors
- •Pharmacology
- •Postoperative care
- •References
- •Diagnosis and management of inhalation injury
- •Introduction
- •Effects of inhaled gases
- •Carbon monoxide
- •Cyanide toxicity
- •Upper airway injury
- •Lower airway injury
- •Diagnosis
- •Resuscitation after inhalation injury
- •Other treatment issues
- •Prognosis
- •Conclusions
- •References
- •Respiratory management
- •Airway management
- •(a) Endotracheal intubation
- •(b) Elective tracheostomy
- •Chest escharotomy
- •Conventional mechanical ventilation
- •Introduction
- •Pathophysiological principles
- •Low tidal volume and limited plateau pressure approaches
- •Permissive hypercapnia
- •The open-lung approach
- •PEEP
- •Lung recruitment maneuvers
- •Unconventional mechanical ventilation strategies
- •High-frequency percussive ventilation (HFPV)
- •High-frequency oscillatory ventilation
- •Airway pressure release ventilation (APRV)
- •Ventilator associated pneumonia (VAP)
- •(a) Prevention
- •(b) Treatment
- •References
- •Organ responses and organ support
- •Introduction
- •Burn shock and resuscitation
- •Post-burn hypermetabolism
- •Individual organ systems
- •Central nervous system
- •Peripheral nervous system
- •Pulmonary
- •Cardiovascular
- •Renal
- •Gastrointestinal tract
- •Conclusion
- •References
- •Critical care of thermally injured patient
- •Introduction
- •Oxidative stress control strategies
- •Fluid and cardiovascular management beyond 24 hours
- •Other organ function/dysfunction and support
- •The nervous system
- •Respiratory system and inhalation injury
- •Renal failure and renal replacement therapy
- •Gastro-intestinal system
- •Glucose control
- •Endocrine changes
- •Stress response (Fig. 2)
- •Low T3 syndrome
- •Gonadal depression
- •Thermal regulation
- •Metabolic modulation
- •Propranolol
- •Oxandrolone
- •Recombinant human growth hormone
- •Insulin
- •Electrolyte disorders
- •Sodium
- •Chloride
- •Calcium, phosphate and magnesium
- •Calcium
- •Bone demineralization and osteoporosis
- •Micronutrients and antioxidants
- •Thrombosis prophylaxis
- •Conclusion
- •References
- •Treatment of infection in burns
- •Introduction
- •Clinical management strategies
- •Pathophysiology of the burn wound
- •Burn wound infection
- •Cellulitis
- •Impetigo
- •Catheter related infections
- •Urinary tract infection
- •Tracheobronchitis
- •Pneumonia
- •Sepsis in the burn patient
- •The microbiology of burn wound infection
- •Sources of organisms
- •Gram-positive organisms
- •Gram-negative organisms
- •Infection control
- •Pharmacological considerations in the treatment of burn infections
- •Topical antimicrobial treatment
- •Systemic antimicrobial treatment (Table 3)
- •Gram-positive bacterial infections
- •Enterococcal bacterial infections
- •Gram-negative bacterial infections
- •Treatment of yeast and fungal infections
- •The Polyenes (Amphotericin B)
- •Azole antifungals
- •Echinocandin antifungals
- •Nucleoside analog antifungal (Flucytosine)
- •Conclusion
- •References
- •Acute treatment of severely burned pediatric patients
- •Introduction
- •Initial management of the burned child
- •Fluid resuscitation
- •Sepsis
- •Inhalation injury
- •Burn wound excision
- •Burn wound coverage
- •Metabolic response and nutritional support
- •Modulation of the hormonal and endocrine response
- •Recombinant human growth hormone
- •Insulin-like growth factor
- •Oxandrolone
- •Propranolol
- •Glucose control
- •Insulin
- •Metformin
- •Novel therapeutic options
- •Long-term responses
- •Conclusion
- •References
- •Adult burn management
- •Introduction
- •Epidemiology and aetiology
- •Pathophysiology
- •Assessment of the burn wound
- •Depth of burn
- •Size of the burn
- •Initial management of the burn wound
- •First aid
- •Burn blisters
- •Escharotomy
- •General care of the adult burn patient
- •Biological/Semi biological dressings
- •Topical antimicrobials
- •Biological dressings
- •Other dressings
- •Exposure
- •Deep partial thickness wound
- •Total wound excision
- •Serial wound excision and conservative management
- •Full thickness burns
- •Excision and autografting
- •Topical antimicrobials
- •Large full thickness burns
- •Serial excision
- •Mixed depth burn
- •Donor sites
- •Techniques of wound excision
- •Blood loss
- •Antibiotics
- •Anatomical considerations
- •Skin replacement
- •Autograft
- •Allograft
- •Other skin replacements
- •Cultured skin substitutes
- •Skin graft take
- •Rehabilitation and outcome
- •Future care
- •References
- •Burns in older adults
- •Introduction
- •Burn injury epidemiology
- •Pathophysiologic changes and implications for burn therapy
- •Aging
- •Comorbidities
- •Acute management challenges
- •Fluid resuscitation
- •Burn excision
- •Pain and sedation
- •End of life decisions
- •Summary of key points and recommendations
- •References
- •Acute management of facial burns
- •Introduction
- •Anatomy and pathophysiology
- •Management
- •General approach
- •Airway management
- •Facial burn wound management
- •Initial wound care
- •Topical agents
- •Biological dressings
- •Surgical burn wound excision of the face
- •Wound closure
- •Special areas and adjacent of the face
- •Eyelids
- •Nose and ears
- •Lips
- •Scalp
- •The neck
- •Catastrophic injury
- •Post healing rehabilitation and scar management
- •Outcome and reconstruction
- •Summary
- •References
- •Hand burns
- •Introduction
- •Initial evaluation and history
- •Initial wound management
- •Escharotomy and fasciotomy
- •Surgical management: Early excision and grafting
- •Skin substitutes
- •Amputation
- •Hand therapy
- •Secondary reconstruction
- •References
- •Treatment of burns – established and novel technology
- •Introduction
- •Partial thickness burns
- •Biological membranes – amnion and others
- •Xenograft
- •Full thickness burns
- •Dermal analogs
- •Keratinocyte coverage
- •Facial transplantation
- •Tissue engineering and stem cells
- •Gene therapy and growth factors
- •Conclusion
- •References
- •Wound healing
- •History of wound care
- •Types of wounds
- •Mechanisms of wound healing
- •Hemostasis
- •Proliferation
- •Epithelialization
- •Remodeling
- •Fetal wound healing
- •Stem cells
- •Abnormal wound healing
- •Impaired wound healing
- •Hypertrophic scars and keloids
- •Chronic non-healing wounds
- •Conclusions
- •References
- •Pain management after burn trauma
- •Introduction
- •Pathophysiology of pain after burn injuries
- •Nociceptive pain
- •Neuropathic pain
- •Sympathetically Maintained Pain (SMP)
- •Pain rating and documentation
- •Pain management and analgesics
- •Pharmacokinetics in severe burns
- •Form of administration [21]
- •Non-opioids (Table 1)
- •Paracetamol
- •Metamizole
- •Non-steroidal antirheumatics (NSAID)
- •Selective cyclooxygenasis-2-inhibitors
- •Opioids (Table 2)
- •Weak opioids
- •Strong opioids
- •Other analgesics
- •Ketamine (see also intensive care unit and analgosedation)
- •Anticonvulsants (Gabapentin and Pregabalin)
- •Antidepressants with analgesic effects
- •Regional anesthesia
- •Pain management without analgesics
- •Adequate communication
- •Psychological techniques [65]
- •Transcutaneous electrical nerve stimulation (TENS)
- •Particularities of burn pain
- •Wound pain
- •Breakthrough pain
- •Intervention-induced pain
- •Necrosectomy and skin grafting
- •Dressing change of large burn wounds and removal of clamps in skin grafts
- •Dressing change in smaller burn wounds, baths and physical therapy
- •Postoperative pain
- •Mental aspects
- •Intensive care unit
- •Opioid-induced hyperalgesia and opioid tolerance
- •Hypermetabolism
- •Psychic stress factors
- •Risk of infection
- •Monitoring [92]
- •Sedation monitoring
- •Analgesia monitoring (see Fig. 2)
- •Analgosedation (Table 3)
- •Sedation
- •Analgesia
- •References
- •Nutrition support for the burn patient
- •Background
- •Case presentation
- •Patient selection: Timing and route of nutritional support
- •Determining nutritional demands
- •What is an appropriate initial nutrition plan for this patient?
- •Formulations for nutritional support
- •Monitoring nutrition support
- •Optimal monitoring of nutritional status
- •Problems and complications of nutritional support
- •Conclusion
- •References
- •HBO and burns
- •Historical development
- •Contraindications for the use of HBO
- •Conclusion
- •References
- •Nursing management of the burn-injured person
- •Introduction
- •Incidence
- •Prevention
- •Pathophysiology
- •Severity factors
- •Local damage
- •Fluid and electrolyte shifts
- •Cardiovascular, gastrointestinal and renal system manifestations
- •Types of burn injuries
- •Thermal
- •Chemical
- •Electrical
- •Smoke and inhalation injury
- •Clinical manifestations
- •Subjective symptoms
- •Possible complications
- •Clinical management
- •Non-surgical care
- •Surgical care
- •Coordination of care: Burn nursing’s unique role
- •Nursing interventions: Emergent phase
- •Nursing interventions: Acute phase
- •Nursing interventions: Rehabilitative phase
- •Ongoing care
- •Infection prevention and control
- •Rehabilitation medicine
- •Nutrition
- •Pharmacology
- •Conclusion
- •References
- •Outpatient burn care
- •Introduction
- •Epidemiology
- •Accident causes
- •Care structures
- •Indications for inpatient treatment
- •Patient age
- •Total burned body surface area (TBSA)
- •Depth of the burn
- •Pre-existing conditions
- •Accompanying injuries
- •Special injuries
- •Treatment
- •Initial treatment
- •Pain therapy
- •Local treatment
- •Course of treatment
- •Complications
- •Infections
- •Follow-up care
- •References
- •Non-thermal burns
- •Electrical injury
- •Introduction
- •Pathophysiology
- •Initial assessment and acute care
- •Wound care
- •Diagnosis
- •Low voltage injuries
- •Lightning injuries
- •Complications
- •References
- •Symptoms, diagnosis and treatment of chemical burns
- •Chemical burns
- •Decontamination
- •Affection of different organ systems
- •Respiratory tract
- •Gastrointestinal tract
- •Hematological signs
- •Nephrologic symptoms
- •Skin
- •Nitric acid
- •Sulfuric acid
- •Caustic soda
- •Phenol
- •Summary
- •References
- •Necrotizing and exfoliative diseases of the skin
- •Introduction
- •Necrotizing diseases of the skin
- •Cellulitis
- •Staphylococcal scalded skin syndrome
- •Autoimmune blistering diseases
- •Epidermolysis bullosa acquisita
- •Necrotizing fasciitis
- •Purpura fulminans
- •Exfoliative diseases of the skin
- •Stevens-Johnson syndrome
- •Toxic epidermal necrolysis
- •Conclusion
- •References
- •Frostbite
- •Mechanism
- •Risk factors
- •Causes
- •Diagnosis
- •Treatment
- •Rewarming
- •Surgery
- •Sympathectomy
- •Vasodilators
- •Escharotomy and fasciotomy
- •Prognosis
- •Research
- •References
- •Subject index

L. C. Woodson et al.
because the gluconate form requires hepatic metabolism to release ionized calcium. Other potential complications of blood transfusion include hemolytic and non-hemolytic transfusion reactions and dilutional thrombocytopenia.
Transfusion-related acute lung injury (TRALI) is defined as a new acute lung injury occurring within 6 hours of transfusion in a patient without additional risk factors for acute lung injury [28]. TRALI is the leading cause of mortality associated with blood transfusion. The greatest risk of TRALI is associated with blood products that contain large amounts of plasma, namely FFP and platelets. As with ARDS, there are no specific therapies for TRALI and management is supportive. It is difficult to recognize TRALI in patients with major burns since there are multiple etiologies for acute lung injury and ARDS in these patients. The risk of TRALI has been reduced by institution of a blood bank policy of minimizing preparation of plasma rich components (e. g. FFP and platelets) from donors who are known to be or are at risk of becoming alloimunized against leukocytes [29].
Postoperative care
Concerns regarding postoperative care of the burn patient are highly variable depending on the patient’s preoperative condition and the intraoperative course. Postoperative physiological condition can be influenced negatively by the presence of inhalation injury and by metabolic, coagulation, and hemodynamic problems associated with hypothermia, massive transfusion, or systemic inflammatory response to debridement of infected tissues. In addition, analgesia and sedation needs of burn patients are often exaggerated in the postoperative period.
The decision to extubate the burn patient postoperatively must take into account potential pulmonary dysfunction due to inhalation injury or intraoperative acute lung injury associated with sepsis or systemic inflammatory response as well as the hemodynamic stability of the patient. Analysis of arterial blood gases provides valuable information regarding pulmonary function and metabolic status prior to extubation. Additionally, airway distortion and obstruction from edema can preclude postoperative
extubation. The degree of airway edema can be estimated by direct inspection using a bronchoscope or laryngoscope.
Monitoring needs during transport to the intensive care unit should be established and equipment assembled early to avoid delays in transportation after surgery is complete. Resuscitation drugs and an easily accessible site for intravenous drug administration should be made available prior to transport of potentially unstable patients.
After transport to the intensive care unit, transfer of care requires a concise report of intraoperative events relative to postoperative care as well as fluids administered and estimated blood loss. Surgical debridement, skin harvesting and grafting are painful procedures. Since poorly controlled pain and anxiety can adversely affect wound healing and psychological outcome it is important that pain and anxiety be adequately treated. Tolerance to morphine often occurs in patients with large burn injuries and may necessitate larger doses or may be associated with hyperalgesia that is poorly controlled with morphine. The use of other analgesics such as methadone, fentanyl or alpha-2 adrenergic agonists have been found to be effective when this occurs [30–31]. Anxiolytic agents are also beneficial in burned patients, especially if prolonged mechanical ventilation is required. Agents such as benzodiazepines, alpha-2 adrenergic agonists and propofol are commonly used to provide anxiolysis.
A chest radiograph may be needed to confirm position of an endotracheal tube or central venous catheter or to rule out complications of central venous cannulation. Since maintenance of body temperature can be challenging during burn surgery and hypothermia is poorly tolerated by burn patients, postoperative temperature should be determined on arrival in the intensive care unit and facilities should be available to treat hypothermia promptly, if it occurs. Blood gas analysis and other laboratory studies should be initiated soon after arrival in the intensive care unit in order to identify any pulmonary or metabolic disturbances that require treatment. Ongoing blood loss can be concealed by bulky burn wound dressings and dilutional coagulopathy can occur after massive transfusion. If ongoing hemorrhage requiring transfusion is suspected, a blood warmer should be used to avoid hypothermia. These
160

Anesthesia for patients with acute burn injuries
patients should be monitored carefully for hemodynamic instability or significant decrease in hemoglobin that might indicate continued hemorrhage.
References
[1]Brigham PA, Dimick AR (2008) The evolution of burn care facilities in the United States. J Burn Care Res 29(1): 248–256
[2]Latenser BA (2009) Critical care of the burn patient: the first 48 hours. Crit Care Med 37(10): 2819–2826
[3]Muehlberger T, Kunar D, Munster A, Couch M (1998) Efficacy of fiberoptic laryngoscopy in the diagnosis of inhalation injuries. Arch Otolaryngol Head Neck Surg 124(9): 1003–1007
[4]Agashe GS, Coakley J, Mannheimer PD (2006) Forehead pulse oximetry: Headband use helps alleviate false low readings likely related to venous pulsation artifact. Anesthesiology 105(6): 1111–1116
[5]Bainbridge LC, Simmons HM, Elliot D (1990) The use of automatic blood pressure monitors in the burned patient. Br J Plast Surg 43(3): 322–324
[6]Kumar A, Anel R, Bunnell E, Habet K, Zanotti S, Marshall S et al (2004) Pulmonary artery occlusion pressure and central venous pressure fail to predict ventricular filling volume, cardiac performance, or the response to volume infusion in normal subjects. Crit Care Med 32(3): 691–699
[7]Holm C, Melcer B, Horbrand F, Worl H, von Donnersmarck GH, Muhlbauer W (2000) Intrathoracic blood volume as an end point in resuscitation of the severely burned: an observational study of 24 patients. J Trauma 48(4): 728–734
[8]Benington S, Ferris P, Nirmalan M (2009) Emerging trends in minimally invasive haemodynamic monitoring and optimization of fluid therapy. Eur J Anaesthesiol 26(11): 893–905
[9]Sakka SG, Becher L, Kozieras J, van Hout N (2009) Effects of changes in blood pressure and airway pressures on parameters of fluid responsiveness. Eur J Anaesthesiol 26(4): 322–327
[10]Pham TN, Cancio LC, Gibran NS (2008) American Burn Association practice guidelines burn shock resuscitation. J Burn Care Res 29(1): 257–266
[11]Alpert RA, Roizen MF, Hamilton WK, Stoney RJ, Ehrenfeld WK, Poler SM et al (1984) Intraoperative urinary output does not predict postoperative renal function in patients undergoing abdominal aortic revascularization. Surgery 95(6): 707–711
[12]Sessler DI (2009) Thermoregulatory defense mechanisms. Crit Care Med 37[7 Suppl]: S203–210
[13]Oda J, Kasai K, Noborio M, Ueyama M, Yukioka T (2009) Hypothermia during burn surgery and postoperative acute lung injury in extensively burned patients. J Trauma 66(6): 1525–9; discussion 9–30
[14]Singer AJ, Taira BR, Thode HC, Jr, McCormack JE, Shapiro M, Aydin A et al (2010) The association between hypothermia, prehospital cooling, and mortality in burn victims. Acad Emerg Med 17(4): 456–459
[15]Blanchet B, Jullien V, Vinsonneau C, Tod M (2008) Influence of burns on pharmacokinetics and pharmacodynamics of drugs used in the care of burn patients. Clin Pharmacokinet 47(10): 635–654
[16]Greenhalgh DG (2007) Burn resuscitation. J Burn Care Res 28(4): 555–565
[17]Han T, Harmatz JS, Greenblatt DJ, Martyn JA (2007) Fentanyl clearance and volume of distribution are increased in patients with major burns. J Clin Pharmacol 47(6): 674–680
[18]Glew RH, Moellering RC, Jr, Burke JF (1976) Gentamicin dosage in children with extensive burns. J Trauma 16(10): 819–823
[19]Martyn JA (1995) Basic and clinical pharmacology of the acetylcholine receptor: implications for the use of neuromuscular relaxants. Keio J Med 44(1): 1–8
[20]Martyn JA, Goudsouzian NG, Chang Y, Szyfelbein SK, Schwartz AE, Patel SS (2000) Neuromuscular effects of mivacurium in 2- to 12-yr-old children with burn injury. Anesthesiology 92(1): 31–37
[21]Martyn JA, Vincent A (1999) A new twist to myopathy of critical illness. Anesthesiology 91(2): 337–339
[22]Robertson RD, Bond P, Wallace B, Shewmake K, Cone J (2001) The tumescent technique to significantly reduce blood loss during burn surgery. Burns 27(8): 835–838
[23]Prough DS, Bidani A (1999) Hyperchloremic metabolic acidosis is a predictable consequence of intraoperative infusion of 0.9% saline. Anesthesiology 90(5): 1247–1249
[24]Jungheinrich C, Neff TA (2005) Pharmacokinetics of hydroxyethyl starch. Clin Pharmacokinet 44(7): 681–699
[25]Hardy JF, De Moerloose P, Samama M (2004) Massive transfusion and coagulopathy: pathophysiology and implications for clinical management. Can J Anaesth 51(4): 293–310
[26](2006) Practice guidelines for perioperative blood transfusion and adjuvant therapies: an updated report by the American Society of Anesthesiologists Task Force on Perioperative Blood Transfusion and Adjuvant Therapies. Anesthesiology 105(1): 198–208
[27]Hirshberg A, Dugas M, Banez EI, Scott BG, Wall MJ, Jr, Mattox KL (2003) Minimizing dilutional coagulopathy in exsanguinating hemorrhage: a computer simulation. J Trauma 54(3): 454–463
[28]Toy P, Popovsky MA, Abraham E, Ambruso DR, Holness LG, Kopko PM et al (2005) Transfusion-related acute lung injury: definition and review. Crit Care Med 33(4): 721–726
[29]Wright SE, Snowden CP, Athey SC, Leaver AA, Clarkson JM, Chapman CE et al (2008) Acute lung injury after ruptured abdominal aortic aneurysm repair: the effect of excluding donations from females from the production of fresh frozen plasma. Crit Care Med 36(6): 1796– 1802
161

L. C. Woodson et al.
[30] Williams PI, Sarginson RE, Ratcliffe JM (1998) Use of |
Correspondence: Lee C. Woodson, M. D., Ph.D., Department |
methadone in the morphine-tolerant burned paediat- |
of Anesthesiology, UTMB, Galveston, TX 77550, USA, E-mail: |
ric patient. Br J Anaesth 80(1): 92–95 |
lwoodson@UTMB. EDU |
[31] Kariya N, Shindoh M, Nishi S, Yukioka H, Asada A |
|
(1998) Oral clonidine for sedation and analgesia in a |
|
burn patient. J Clin Anesth 10(6): 514–517 |
|
162